DEFINING CLINICALLY ACTIONABLE SUBTYPES OF CASTRATION RESISTANT PROSTATE CANCER THROUGH EPIGENETIC CELL-FREE DNA ANALYSIS
$1,382,551FY2025Defense Health AgencyDOD
Emory University, Atlanta GA
Investigators
View source on USAspending →DEFINING CLINICALLY ACTIONABLE SUBTYPES OF CASTRATION RESISTANT PROSTATE CANCER THROUGH EPIGENETIC CELL-FREE DNA ANALYSIS · GrantIndex